BRIEF-GlaxoSmithKline says gene therapy for immunodeficiency gets positive CHMP recommendation
April 01, 2016 at 10:12 AM EDT
* Gsk receives positive CHMP opinion in europe for Strimvelis, first gene therapy to treat very rare disease, ADA-SCID